We did it for them. We will do it for you too.

How we helped a London pharma company add
35% to their revenue in 7 months.

We did it for them. We will do it for you too.

How we helped a London pharma company add 35% to their revenue in 7 months.

Companies we arranged meetings with for our clients in the last year:

Companies we arranged meetings with for our clients in the last year:

$10M+

new revenue for clients

26

clients and counting

3K+

agreed meetings

$10M+

new revenue for clients

26

clients and counting

3K+

agreed meetings

WHAT MAKES US DIFFERENT

FOCUS ON WHAT DOES 80% OF THE WORK - GOING DEEPER AT EVERY STAGE

Most B2B acquisition today is noisy, impersonal, and unpredictable.At M&L, we build sales systems using cold email and LinkedIn that deliver qualified opportunities consistently and reliably. We combine positioning, offer design, and case studies with AI research, personalisation, and automation.We deliver value before we ask for a meeting. The result is a predictable pipeline and high-ticket contracts across the globe.

MEET OUR
DIRECT RESPONSE FRAMEWORK

Where you might know us from

WHERE YOU MIGHT MEET US

IF YOU SPOT US ON AN EVENT OR TRAINING, DON'T BE SHY AND COME SAY HI

Why B2B brands are losing the attention war — and what e-commerce already figured out.
Slovakia, 2025

The best conversations happen in front of an audience.

We invest in knowing more than we did last year.

If you walked past our stand, we probably already had a conversation worth having.

Most B2B brands treat marketing like a cost center. The ones winning right now treat it like a product.

Why B2B brands are losing the attention war — and what e-commerce already figured out.
Slovakia, 2025

The best conversations happen in front of an audience.

If you walked past our stand, we probably already had a conversation worth having.

We invest in knowing more than we did last year.

Most B2B brands treat marketing like a cost center. The ones winning right now treat it like a product.

TESTIMONIALS

DON'T JUST TAKE OUR WORD FOR IT

Ivan Berkes

CEO & Founder

London Pharma Capital

Claudio Storelli

CEO & Founder

Storelli

Vladimir Mihalik

COO

Patrone

"The content quality and execution were top-notch, perfectly aligning with our brand’s messaging. The process was smooth, efficient, and hassle-free, making collaboration effortless. Highly recommend their work!"

Annette Jordan

Co-Owner

Effekt Nutrition

"They worked with us to understand our service, branding, and target audience, then they created great AI content - very realistic and vivid. We wanted several rounds of revisions and they were happy to deliver with a fast turnaround time."

Josh Margulies

Head of Marketing

Harbor Care

All was done professionally, independently and at a good cost point.

Ivan | CEO & Owner

London Pharma Capital

We've doubled our adspend and maintained very healthy KPIs.

Claudio | CEO & Founder

Storelli

They literally doubled our revenue within the first 2 months and we have grown month-to-month since, never dipping down.

Vladimír | COO

Patrone

"The content quality and execution were top-notch, perfectly aligning with our brand’s messaging. The process was smooth, efficient, and hassle-free, making collaboration effortless. Highly recommend their work!"

Annette Jordan

Co-Owner

Effekt Nutrition

"They worked with us to understand our service, branding, and target audience, then they created great AI content - very realistic and vivid. We wanted several rounds of revisions and they were happy to deliver with a fast turnaround time."

Josh Margulies

Head of Marketing

Harbor Care

$192,256 in opportunities generated in one quarter. From cold outreach alone.

Why our e-comm background makes us better at B2B

WHY
our e-comm background makes us better at B2B

Why are B2B companies, with better products, bigger contracts, and longer relationships, being marketed so poorly?

"In e-commerce, you learn quickly or you lose money. We learned quickly."

We saw B2B companies with genuinely great products sitting invisible. The gap was not the product. It was the marketing. And the marketing was slow, safe, and years behind.We did not pivot away from performance marketing. We brought it into an industry that had been waiting for it.

6 yrs

In performance marketing before B2B

Built during one of the hardest periods in digital advertising history

10+

Brands grown from unknown to recognised

7%

Reply rate in B2B

In less than 3 months

6 yrs

In performance marketing before B2B

Built during one of the hardest periods in digital advertising history

10+

Brands grown from unknown to recognised

7%

Reply rate in B2B

In less than 3 months

CASE STUDIES

RESULTS SPEAK LOUDER THAN PROMISES

function triggerModal() { document.getElementById("popup").style.display = "flex"; }
function triggerModal2() { document.getElementById("popup2").style.display = "flex"; }
×

TRUE CLASSIC

65% ROAS Growth & 28% CAC Reduction In 90 Days.

The Problem

True Classic had already gained impressive traction in the U.S. market, achieving significant revenue milestones through a mix of influencer marketing and performance campaigns. However, their German market presence was underdeveloped. They had not yet fully localized their offering or ad strategy, and CAC (Customer Acquisition Costs) were unoptimized due to language and cultural mismatches. The key challenges included scaling in a new international market (Germany), lack of localized creatives and funnels, and misaligned ad copy that didn’t resonate with the German audience. Their Meta ads were underperforming in the region, and their e-commerce infrastructure wasn’t optimized for German-speaking users.

The Solution

We developed a comprehensive localization strategy — beginning with market research and cultural insights to tailor the messaging and creative direction. We translated and transcreated ad copy, implemented new German UGC and video content, and launched localized Meta and Google campaigns. Additionally, we optimized their landing pages and checkout flow for the German market. We also collaborated with the U.S. growth team to maintain consistent brand voice while adapting to regional expectations. Within 3 months, ROAS improved by over 65% compared to previous attempts. We achieved a CAC reduction of ~28% and reached profitability in the German market. The brand saw consistent revenue growth, increased retention, and valuable learnings that informed their broader EU expansion strategy. We successfully proved the viability of the German market for True Classic, built a repeatable blueprint for international scaling, and received an internal referral for further collaboration on other markets.

function triggerModal3() { document.getElementById("popup3").style.display = "flex"; }
×

NATURAL MOJO

20% Conversion Rate Increase & 15-Person Team Built & Restructured.

The Problem

When we joined, Natural Mojo had hit a plateau in growth. ROAS was declining, influencer budgets were bloated, and retention was weak. Their online store was outdated, and internal communication between content, performance, and CRM teams was fragmented. The key challenges were rising CAC, declining ROAS, disjointed performance strategy, poor retention, and lack of an integrated BI solution. Additionally, the influencer strategy wasn’t tied to measurable KPIs, and product storytelling needed refinement.

The Solution

We built and restructured a 15-person team across e-commerce, performance, content, CRM, and BI. We introduced a new paid media strategy across Meta, Google, Pinterest, and TikTok, set clear ROAS targets, implemented Triple Whale for attribution, and rebuilt the webshop on Shopify. We also introduced new upsell funnels and improved UGC content quality and quantity. Within months, we restored profitability in paid channels, increased Shopify conversion rate by over 20%, and lowered CAC through smart influencer partnerships. Our top-funnel to bottom-funnel synergy improved dramatically, and UGC became a core asset across platforms. We successfully turned around a stagnating brand, rebuilt its tech and marketing stack, and made it the most profitable DTC business in The Brand Base portfolio at the time.

Quick Transformations

It doesn't take ages to achieve the goal, just a proper strategy.

BOOK YOUR DEMO

TAKE THE FIRST STEP WITH NO-STRING-ATTACHED CALL

Copyright © 2026 - M&L Creative | All Rights Reserved.

Curious about what this could look like for you?

Book 30 minutes and find out whether we are the right agency for where you want to go next.

Thank you for booking in a call!

We can't wait to talk and help you grow your brand.

IMPORTANT STEP!

IMPORTANT STEP!

Accept Your Email Invitation

Accept Your Email Invitation

1. Search your inbox for "M&L Creative"2. Click "Add to calendar"3. Click "Yes" for the event invitation

Make sure to check our PORTFOLIO prior to our call.

How M&L Drove 35% Revenue Growth for London Pharma Capital

London Pharma Capital had a strong product but a broken outreach engine, relying on referrals and cold calls that led nowhere. In 7 months, M&L built a full B2B acquisition system that delivered 35% revenue growth and an 8.2x return on investment.

Revenue Impact

ROI

Timeline

+35%

8.2x

7 mo

growth in 2025

return on investment

from kickoff to result

Revenue Impact

+35%

growth in 2025

ROI

8.2x

return on investment

Timeline

7 mo

from kickoff to result

The challenge

  • London Pharma Capital had plateaued on referral-driven growth and a cold calling operation that generated little qualified pipeline - the sales team was spending the majority of its time chasing unresponsive or low-fit prospects with no systematic way to change that.

  • The company had no defined Ideal Customer Profile, no case study assets to build trust with new prospects, and no consistent marketing message - each outreach attempt was effectively starting from scratch, making it impossible to build momentum or measure what worked.

  • Without a predictable acquisition channel, monthly revenue was inconsistent and forecasting was unreliable. Continued dependency on warm introductions meant growth was capped by the founders' personal networks rather than by the strength of the product itself.

Our approach

Our approach

01

Go-To-Market FoundationWe interviewed London Pharma Capital's best clients to extract the real language of their buying decision — building an ICP, five case studies, and a value-first offer that was positioned around proven outcomes rather than product features.

02

Education-Based OutreachInstead of sending standard cold pitches, we launched personalised email campaigns inviting decision-makers to a free keynote session on a high-relevance industry challenge. This drove a 20%+ positive reply rate while positioning the client as a trusted expert from the first touchpoint.

03

Sales Development SystemWe built and managed the full SDR layer — 50 outbound accounts, 250 personalised emails per day, automated follow-up sequences across email, LinkedIn and WhatsApp — delivering a consistent flow of 20+ qualified meetings per month into the client's calendar.

04

Keynote-Led Sales CollaborationWe designed a structured 3-step sales cycle — Discovery Call, Keynote, and Sales Debrief — where each meeting built trust and pre-handled objections. We provided scripting, call review, and live coaching to help the internal team close at a significantly higher rate.

Execution timeline

WEEKS 1–2 AUDIT & FOUNDATIONFull audit of the existing sales process, marketing materials, and client base. Conducted structured interviews with London Pharma Capital's top clients to extract buying motivations, pain language, and outcome data. Defined the Ideal Customer Profile and began building the prospect database.WEEK 3 — STRATEGY & ASSET BUILDDeveloped the core marketing message and value-first offer. Produced five case studies from the client interviews. Built five outbound email campaign variants with personalised messaging angles, a multi-step follow-up sequence (3-7-30 days), and the technical email infrastructure — 10 domains, 50 sending accounts.WEEK 4 — CAMPAIGN LAUNCH & OPTIMISATIONCampaigns went live. Daily monitoring of open rates, reply rates, and booking conversion. A/B tested subject lines and personalisation hooks. First qualified meetings booked within the first week of sending. SDR follow-up processes activated across LinkedIn and WhatsApp to maximise show-up rates.MONTHS 2–7 — SCALE & SALES COLLABORATIONExpanded the database and introduced new campaign angles based on market feedback. Keynote sessions were refined using post-call debrief data. Weekly reporting and strategy reviews ensured KPIs were consistently hit and the sales team was coached to close an increasing share of the qualified pipeline independently.

WEEKS 1–2 AUDIT & FOUNDATIONFull audit of the existing sales process, marketing materials, and client base. Conducted structured interviews with London Pharma Capital's top clients to extract buying motivations, pain language, and outcome data. Defined the Ideal Customer Profile and began building the prospect database.WEEK 3 — STRATEGY & ASSET BUILDDeveloped the core marketing message and value-first offer. Produced five case studies from the client interviews. Built five outbound email campaign variants with personalised messaging angles, a multi-step follow-up sequence (3-7-30 days), and the technical email infrastructure — 10 domains, 50 sending accounts.WEEK 4 — CAMPAIGN LAUNCH & OPTIMISATIONCampaigns went live. Daily monitoring of open rates, reply rates, and booking conversion. A/B tested subject lines and personalisation hooks. First qualified meetings booked within the first week of sending. SDR follow-up processes activated across LinkedIn and WhatsApp to maximise show-up rates.MONTHS 2–7 — SCALE & SALES COLLABORATIONExpanded the database and introduced new campaign angles based on market feedback. Keynote sessions were refined using post-call debrief data. Weekly reporting and strategy reviews ensured KPIs were consistently hit and the sales team was coached to close an increasing share of the qualified pipeline independently.

Results

Results

+35% Revenue Growth

New B2B clients acquired through the outbound system, generating a consistent and scalable revenue stream within 7 months.

80%+ Meeting Show-Up Rate

Multi-channel pre-meeting nurturing (email, LinkedIn, WhatsApp) virtually eliminated no-shows, maximising the return on every booked slot.

20%+ Positive Reply Rate

Education-based cold email campaigns outperformed industry benchmarks by 4–5x, reaching senior decision-makers at target companies who had previously been unreachable.

8.2x Return on Investment

Total revenue generated through the partnership far exceeded the investment in M&L's system — with the infrastructure now fully operational and continuing to compound.

"Before working with M&L, we were entirely dependent on referrals and had no reliable way to reach new clients. Within a few months we had a full pipeline of qualified prospects and were closing deals we simply couldn't have reached on our own."

Managing Director — London Pharma Capital

"Before working with M&L, we were entirely dependent on referrals and had no reliable way to reach new clients. Within a few months we had a full pipeline of qualified prospects and were closing deals we simply couldn't have reached on our own."

Managing Director — London Pharma Capital

Key takeaway

London Pharma Capital's results demonstrate what becomes possible when B2B acquisition is treated as an end-to-end system — not a series of disconnected tactics. By combining a data-driven offer with education-based outreach and a structured sales process, M&L turned an unpredictable revenue engine into a consistent, scalable one. If your business is ready to move beyond referrals and build a pipeline that works without cold calling, we'd like to show you exactly how.